| Literature DB >> 30201602 |
Laura Ospina-Pinillos1, Tracey Davenport1, Frank Iorfino1, Ashleigh Tickell1, Shane Cross1, Elizabeth M Scott2, Ian B Hickie1.
Abstract
BACKGROUND: Globally there is increasing recognition that new strategies are required to reduce disability due to common mental health problems. As 75% of mental health and substance use disorders emerge during the teenage or early adulthood years, these strategies need to be readily accessible to young people. When considering how to provide such services at scale, new and innovative technologies show promise in augmenting traditional clinic-based services.Entities:
Keywords: mental health; primary health care; staging model; symptom assessment health service reform; telemedicine
Mesh:
Year: 2018 PMID: 30201602 PMCID: PMC6231849 DOI: 10.2196/jmir.9966
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Interrater agreement between online rater A and online rater B by assignment of clinical stage.
| Online rater A | ||
| Online rater B | Stage 1a (n=16), n (%) | Stage 1b+ (n=32), n (%) |
| Stage 1a (n=17), n (%) | 14 (29) | 3 (6) |
| Stage 1b+ (n=31), n (%) | 2 (4) | 29 (61) |
Interrater agreement between face-to-face and online clinicians by allocation to clinical stage.
| Online assessment | ||
| Face-to-face clinical assessment | Stage 1a (n=27), n (%) | Stage 1b+ (n=45), n (%) |
| Stage 1a (n=42), n (%) | 23 (32) | 19 (26) |
| Stage 1b+ (n=30), n (%) | 4 (6) | 26 (36) |
Median scores and significance test results for self-reported variables among groups.
| Characteristics | Stage 1a (agree)a (n=23), n (%) | Stage 1b+ (agree)b (n=26), n (%) | Stage 1b+ (disagree)c (n=19), n (%) | Significance test | Post hoc | |||
| a vs c | b vs c | |||||||
| Female, n (%) | 15 (65) | 18 (69) | 14 (74) | 1.70e (.72) | —f | — | ||
| Age in years, median (IQR)g | 20.00 (4) | 20.50 (4) | 21.00 (4) | 0.78d (.86) | — | — | ||
| 1.58e (.71) | ||||||||
| Secondary, n (%) | 12 (52) | 14 (54) | 8 (42) | — | — | — | ||
| Tertiary, n (%) | 11 (48) | 12 (46) | 11 (58) | — | — | — | ||
| K-10h, median (IQR) | 25 (13) | 32.0 (9) | 28.0 (13) | 5.51d (.14) | — | — | ||
| Depression/anxiety (current), n (%) | 16 (70) | 22 (85) | 14 (74) | 6.03e (.09) | — | — | ||
| Hypomanic-like issue (current), n (%) | 5 (22) | 10 (38) | 6 (32) | 2.91e (.38) | — | — | ||
| Psychotic-like issue (current), n (%) | 5 (22) | 12 (46) | 7 (37) | 4.92e (.15) | — | — | ||
| Mental health history, n (%) | 11 (48) | 20 (77) | 18 (95) | 11.83e (.005) | .001 | .21 | ||
| Lifetime self-harm, n (%) | 7 (30) | 20 (77) | 7 (37) | 13.28e (.003) | .67 | .007 | ||
| SIDASi, median (IQR) | 1 (4) | 9.5 (24) | 1 (5) | 12.59d (.006) | .71 | .008 | ||
| Suicide planning history, n (%) | 0 (0) | 12 (46) | 7 (37) | 17.75e (<.001) | .002 | .53 | ||
| Suicide attempt history, n (%) | 0 (0) | 6 (23) | 1 (5) | 6.98e (.04) | .45 | .21 | ||
| Lifetime substance misuse, n (%) | 17 (74) | 18 (69) | 14 (74) | 0.36e (.98) | — | — | ||
| Cannabis weekly, n (%) | 1 (4) | 8 (31) | 6 (32) | 7.60e (.04) | .03 | .95 | ||
| Substances to cope with emotions, n (%) | 6 (26) | 18 (69) | 8 (42) | 10.85e (.009) | .24 | .07 | ||
aStage 1a by online and face-to-face clinicians.
bStage 1b+ by online and face-to-face clinicians.
cStage 1b+ by online clinicians but assessed as Stage 1a by face-to-face clinicians.
dKruskal–Wallis test, 2-tailed.
eFET: Fisher exact test, 2-tailed.
fNot applicable.
gIQR: Interquartile range.
hK-10: 10-item Kessler Psychological Distress Scale.
iSIDAS: Suicidal Ideation Attributes Scale.
Median scores and significance test results for clinician-reported variables among groups.
| Tests | Stage 1a (agree)a (n=23), n (%) | Stage 1b+ (agree)b (n=26), n (%) | Stage 1b+ (disagree)c (n=19), n (%) | Significance test | Post hoc | ||||||||
| a vs c | b vs c | ||||||||||||
| Face-to-face, median (IQR)f | 2.0 (1) | 3.0 (2) | 1.0 (1) | 37.04 (<.001) | .83 | <.001 | |||||||
| Online, median (IQR) | 2.0 (1) | 4.0 (1) | 3.0 (1) | 35.29 (<.001) | <.001 | .01 | |||||||
| Face-to-face, median (IQR) | 75.0 (9) | 69.0 (15) | 75.0 (5) | 12.17 (.007) | .10 | .08 | |||||||
| Online, median (IQR) | 75.0 (9) | 60.0 (10) | 71.0 (10) | 25.33 (<.001) | .01 | .003 | |||||||
aStage 1a by online and face-to-face clinicians.
bStage 1b+ by online and face-to-face clinicians.
cStage 1b+ by online clinicians but assessed as stage 1a by face-to-face clinicians.
dKruskal–Wallis test, 2-tailed.
eCGI-S: Clinical Global Impression Scale–Severity.
fIQR: Interquartile range.
gSOFAS: Social and Occupational Functioning Assessment Scale.